← Back to all signals
RESEARCH PAPER ANALYSIS

Aliança AMARTE: A Collaborative Network to Improve Oncologic Pediatric Care in Brazil.

AI interpretation is pending for this paper.

Open original publication →
PMID40903979
JournalPediatric blood & cancer
Publication Date2025-09-03
Ingested2026-08-02 12:05 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

INTRODUCTION: In Brazil, inequalities in access to treatment and survival of childhood cancer are observed across different geographic regions. In 2014, under the coordination of Hospital de Câncer Infantojuvenil de Barretos (Fundação Pio XII), six hospitals met weekly for case discussion. In 2019, the AMARTE (Apoio Maior Aumentando Recursos e Treinamentos Especializados) Alliance officially began with the aim to improve the quality of pediatric oncology care in Brazil and became a collaborative network of innovation, research, and learning with 31 member institutions in 2024. METHODS: AMARTE follows four strategic pillars: (1) equalize diagnostics, (2) homogenize treatment, (3) epidemiological and survival studies, and (4) scientific development and innovation. Fundação Pio XII and St. Jude Children's Research Hospital provide infrastructure and human resources. Implementation resources are supported mainly by the member institution. The first strategic goal was to maintain sustainable member engagement. A semestral assessment (SCORE) monitors the progress and engagement level, based on defined indicators. RESULTS: Three engagement reports have been published, with an increase in members' scores: 17 hospitals increased their SCORE, 7 decreased, and 1 hospital did not change. Key achievements include a common data registry, diagnostic and treatment protocols, regular technical-scientific meetings, and the formation of a fundraising group to achieve financial sustainability. CONCLUSION: The first decade of the AMARTE Alliance highlights the relevance of collaboration in pediatric oncology. Challenges refer to the sustainable participation of specialists and heterogeneous governance structure across members, requiring flexibility in the implementation of shared initiatives. Outcome indicators are being developed to assess long-term impact.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Analysis of Ocular Surface Tumours and Lesions by High-definition Anterior-segment Optical Coherence Tomography. Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH 70.6 2 Preliminary Validation of a Self-Reported Functional Outcomes Tool for Children with Extremity Tumors: Translation into Persian and Assessment of the Reliability and Validity of the pTESS-Leg Questionnaire. Medical journal of the Islamic Republic of Iran 58.4 3 Metastatic HER2-positive breast cancer in a 19-year-old woman following a 4-year diagnostic delay: a case report. AME case reports 55.4 4 A hepatic malignant spindle-cell neoplasm of uncertain lineage clinically favoring sarcomatoid hepatocellular carcinoma: a case report. AME case reports 58.2 5 Second-Course Reirradiation Versus No Reirradiation in Pediatric Diffuse Intrinsic Pontine Glioma: A Meta-Analysis of Survival Outcomes. Pediatric neurology 81.62 6 Role of genomic testing in modern diagnostic surgical pathology practice. Pathology 62.3 7 Asperginase-based chemotherapy regimen for acute lymphoblastic leukemia: A cohort study with promising outcomes on adults. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 77.34 8 Pediatric lymphomatoid papulosis: a broad clinicopathologic spectrum including rare variants in a single-center case series. Frontiers in medicine 57.8 9 Safety and surgical outcomes of sodium fluorescein-guided pediatric brain tumor surgery: a retrospective before-and-after single-center cohort study. Frontiers in surgery 61.7 10 URGCP promotes osteosarcoma progression by regulating the ESCRT-III subunit CHMP4B. Translational cancer research 55.8 11 Sequential chemoradiotherapy vs. radiotherapy alone or concurrent chemoradiotherapy after radical resection of stage IA2-IIA1 cervical cancer: a retrospective cohort study. Translational cancer research 77.74 12 Lnc-TIM3 promotes acute lymphoblastic leukemia progression through miR-5094-mediated regulation of TIM3. Translational cancer research 52.9 13 [Adherence to Hepatocellular Carcinoma Surveillance and Its Association with Tumor Stage at Diagnosis: Experience at a University Hospital]. Acta gastroenterologica Latinoamericana 67.0 14 Quantitative and qualitative magnetic resonance imaging-based analysis to predict postoperative disease progression in hepatocellular carcinoma. Medical physics 63.7 15 Cross-Sectional Profiling of Aqueous Humor VEGF-A Reflects the Tumor and Ocular Microenvironment in Retinoblastoma. Investigative ophthalmology & visual science 64.4 16 What is in the Dust? Species-Level Profiling Reveals Pathogenic and Protective Potential of Microbial Communities in Daycare and Home Environments. Environmental microbiology reports 37.0 17 Successful management of long-term venovenous ECMO for severe PARDS in a child with acute lymphoblastic leukemia. Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs 57.6 18 Ovarian Yolk Sac Tumor in a 10-Year-Old Girl Following Metachronous Bilateral Mature Ovarian Teratomas. Case reports in obstetrics and gynecology 60.4 19 High-risk Human Papillomavirus Genotypes in Women Undergoing Cervical Screening in Leshan, China: Real-time and Nested Multiplex PCR. Journal of visualized experiments : JoVE 61.0 20 Generation of an Induced Pluripotent Stem Cell Line from a Patient with Infantile Liver Failure Syndrome 2 Carrying a Compound Heterozygous Mutation in NBAS. Cellular reprogramming 46.5 21 Targeted pharmacotherapy of NF1-associated plexiform neurofibromas: current evidence and future perspectives. Expert opinion on pharmacotherapy 69.44 22 Hijacking Developmental Immunity: Inflammation and Immune Dysregulation in Pediatric Brain Tumors. Neuro-oncology 63.6 23 MGMT expression in pediatric H3 G34-mutant diffuse hemispheric glioma: technical covariates should be addressed before clinical use. Acta neuropathologica 47.5 24 Poor mental health days and depressive disorders comparing non-caregivers, informal non-cancer caregivers, and informal caregivers of cancer patients: BRFSS 2022-23. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 65.5 25 Paediatric thalamic tumours: a predictive MR phenotype. Neuroradiology 59.5 26 International patterns and incidence trends of lung cancer in adolescent and young adults by histological subtype and sex. Annals of the American Thoracic Society 57.5 27 PAX3::FOXO1 and the INO80 complex sustain replication fork progression in fusion positive rhabdomyosarcoma. Molecular cancer research : MCR 48.5 28 Prevalence and geographical distribution of persons with albinism (PWA) in Togo in 2024. PloS one 59.0 29 Selpercatinib in Pediatric and Adolescent Patients With RET-Altered Solid Tumors: Safety and Efficacy Results From the Phase I/II LIBRETTO-121 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 83.4 30 Erratum: Circulating Tumor DNA Profiling Defines Risk Classification in Patients With Ewing Sarcoma: A Report From the Children's Oncology Group and the LEOPARD Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 47.5 31 Genetic hepatocellular cholestasis: an update. Clinics and research in hepatology and gastroenterology 66.0 32 It Is Possible to Save the Kidney With Renal Artery Occlusion Without Autotransplantation: A Case Report. Transplantation proceedings 45.5
PATIENT-FRIENDLY SUMMARY

Aliança AMARTE: A Collaborative Network to Improve Oncologic Pediatric Care in Brazil.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic